Try a new search

Format these results:

Searched for:

person:ashinr01

in-biosketch:true

Total Results:

57


Q-switched ruby laser provides effective treatment for tattoos

Ashinoff R
PMID: 10146465
ISSN: 0746-469x
CID: 13061

Rombo syndrome: a second case report and review [Case Report]

Ashinoff R; Jacobson M; Belsito DV
PMID: 8496444
ISSN: 0190-9622
CID: 6310

Linear nevus sebaceus of Jadassohn treated with the carbon dioxide laser [Case Report]

Ashinoff R
A 10-year-old boy from Guiana was born with a linear nevus sebaceus covering his entire nose from the glabella area to the tip. Cosmetic appearance, which was the major concern of the patient and his family, was greatly improved by the use of the carbon dioxide (CO2) laser. The CO2 laser has not been reported previously as a treatment modality for nevus sebaceus
PMID: 8346119
ISSN: 0736-8046
CID: 13151

Solitary mastocytoma in an adult. Treatment by excision [Case Report]

Ashinoff R; Soter NA; Freedberg IM
BACKGROUND. In approximately 65% of patients, mastocytosis presents between birth and 15 years of age. Although solitary mastocytomas usually appear within the first 3 months of life, in unusual circumstances they may appear in adulthood. OBJECTIVE. The rare entity of solitary mastocytoma in adulthood and the simple treatment method of excision are discussed. METHODS. Simple surgical excision without manipulation of the lesion was performed. RESULTS. The lesion was surgically excised without recurrence. CONCLUSION. Solitary mastocytoma is a rare lesion in adulthood. The differential diagnosis includes a melanocytic nevus, xanthogranuloma and leukemia cutis. Surgical excision offers a rapid, relatively simple and effective mode of treatment
PMID: 8496494
ISSN: 0148-0812
CID: 13164

Rapid response of traumatic and medical tattoos to treatment with the Q-switched ruby laser [Case Report]

Ashinoff R; Geronemus RG
Traumatic tattoos can be very difficult to remove. Excision is often not possible because of the extent of the tattoo, and dermabrasion may not be able to reach the area of pigment without significant scarring. Six patients with traumatic (n = 5) or medical (n = 11) tattoos were treated with the Q-switched ruby laser with complete or nearly complete resolution after one to six treatments without cutaneous scarring or permanent pigmentary alteration
PMID: 8460187
ISSN: 0032-1052
CID: 9176

Failure of the flashlamp-pumped pulsed dye laser to prevent progression to deep hemangioma [Case Report]

Ashinoff R; Geronemus RG
Hemangiomas are common vascular lesions in children. The flashlamp-pumped pulsed dye laser has shown excellent results in the treatment of port-wine stains and, more recently, superficial (capillary) hemangiomas. Four patients with clinically evident superficial hemangiomas illustrate the point that early treatment with this laser may not preclude growth of a deeper component of the lesions
PMID: 8493176
ISSN: 0736-8046
CID: 9177

Q-switched ruby laser treatment of labial lentigos [Case Report]

Ashinoff R; Geronemus RG
The Q-switched ruby laser causes selective damage to pigmented cells in the skin. This laser, which has a wavelength of 694 nm and a pulse duration of 40 nsec, has shown very promising results in the treatment of both amateur and professional tattoos. Less data are available on its ability to treat benign pigmented lesions of the skin. Three patients who had labial lentigos were treated with the Q-switched ruby laser, and dramatic clearing occurred after one or two treatments with a fluence of 10 J/cm2
PMID: 1469132
ISSN: 0190-9622
CID: 9181

Lasers in the treatment of skin cancer

Geronemus R; Ashinoff R
PMID: 1393983
ISSN: 0891-8422
CID: 9183

Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro

Gottlieb AB; Khandke L; Krane JF; Staiano-Coico L; Ashinoff R; Krueger JG
Anthralin is an effective topical treatment for active psoriasis; however, its mechanism of action is unknown. Both TGF-alpha and its receptor, the EGF receptor, are overexpressed in active psoriatic plaques and might, therefore, play a role in psoriatic epidermal hyperplasia. In order to assess whether anthralin might act via alteration of this growth factor pathway, we examined the in vitro effects of pharmacologic concentrations of anthralin on cultured normal human keratinocytes. Keratinocyte proliferation was inhibited by 98% at an anthralin concentration of 10 ng/ml. In contrast, lymphocyte proliferation was inhibited by only 50% at an anthralin concentration of 10 micrograms/ml. Anthralin treatment did not induce cell-cycle-specific growth arrest as assessed by flow-cytometric analysis of acridine-orange-stained keratinocytes. Northern analysis of anthralin-treated keratinocytes demonstrated a marked decrease in TGF-alpha mRNA expression. Anthralin-treated keratinocytes showed decreased binding of 125I-EGF and 125I-IGF-I to their respective receptors, but EGF receptor binding was inhibited to a greater extent. Anthralin decreased ligand-binding affinity and cell-surface numbers of EGF receptors as assessed by Scatchard analysis of 125I-EGF binding to anthralin-treated keratinocytes. These results indicate that anthralin alters components of the EGF receptor pathway in cultured keratinocytes and that these effects might contribute to the clinical efficacy of anthralin in the treatment of active psoriasis
PMID: 1314863
ISSN: 0022-202x
CID: 16100

Treatment of a port-wine stain in a black patient with the pulsed dye laser [Case Report]

Ashinoff R; Geronemus RG
A black man presenting with a port-wine stain was spot-treated with a flashlamp-pumped pulsed dye laser. The 1 cm2 area was treated with the flashlamp-pumped pulsed dye laser using rhodamine in methanol as the dye, a wavelength of 585 nm, a pulse duration of 450 microseconds, and a circular spot size of 5 mm. Energy density was 7.75 J/cm2. Superficial sloughing of the skin was noted immediately posttreatment. Persistent hyperpigmentation, textural changes to the skin, and no improvement in the port-wine stain were noted at follow-ups 2-, 4-, and 8-months posttreatment
PMID: 1537953
ISSN: 0148-0812
CID: 9186